Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02387840 · ClinicalTrials.gov registry record · NA
Feasibility and Clinically Application of Magnetic Resonance Fingerprinting
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02387840 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 35 participants.
The verdict
NCT02387840, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study will look at the feasibility of using magnetic resonance fingerprinting (MRF) in children, adolescents and young adults (AYA) with and without brain tumors. This study will also look at subjects with and without neurofibromatosis type 1(NF1), a genetic disorder that affects the growth of nervous system cells. Further, it will explore potential ways of using of MRF signal measurements in children, adolescents, and young adults with brain tumors, including tissue characterization, looking at whether the treatment was effective, and finding metastasized tumors of unknown origin (occult tumors). To explore the feasibility and potential applications of MRF, this study will recruit up to 80 subjects but will stop once 10 subjects have usable data in each of six groups.
Interventions
- DEVICE Magnetic Resonance Imaging
- DEVICE Magnetic Resonance Fingerprinting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2015-03 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02387840
The ClinicalTrials.gov registry entry for NCT02387840 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT02387840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02387840 about?
NCT02387840 is a clinical study titled "Feasibility and Clinically Application of Magnetic Resonance Fingerprinting". This study will look at the feasibility of using magnetic resonance fingerprinting (MRF) in children, adolescents and young adults (AYA) with and without brain tumors. This study will also look at subjects with and without neurofibromatosis type 1(NF1), a genetic disorder that affects the growth of ...
What is the current status of trial NCT02387840?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2015-03. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT02387840?
The interventions under investigation include: Magnetic Resonance Imaging (DEVICE), Magnetic Resonance Fingerprinting (DEVICE).
Who is sponsoring clinical trial NCT02387840?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.